News and blogs
340 results found.
What does Sajid Javid’s letter to the clinically extremely vulnerable mean?
We've read the 2,000 word letter, digested it, and sum up the key points in 179 words.
My birthday surprise… blood cancer
Due to the severity of his condition, Sunny didn't have time to digest the news of his diagnosis. Now, he has some advice for you.
Our research strategy: your questions answered
We asked our community what they wanted to know about our research strategy and the future of blood cancer research. In this article we answer these important questions – from how we allocate funding, to how soon research should deliver impact for patients.
We didn’t know Dad was still vulnerable to covid. People with blood cancer deserve to be told the truth
Philip's family did everything they could to keep him safe from Covid, but sadly it wasn't enough. Philip's daughter, Gemma, shares their heartbreaking story with the hope that better vaccine information will be given to people with blood cancer in future.
I put my symptoms down to being pregnant, but it was actually blood cancer
Jemma, and many of her healthcare professionals, put her symptoms down to the side effects of being pregnant or giving birth for far too long. After a long road to getting a diagnosis, Jemma is finally receiving the treatment she needs.
The blood cancer jigsaw: how we start to piece together the bigger picture
There are many different types of blood cancer, which affect different blood cells and require different treatments. But blood cancers might be more similar than you think – in this blog we look at what ties them together, the similarities between treatments, and how some drugs and research are having an impact across multiple conditions.
Clinical trials: Everything you didn't know you needed to know
Not many people know that we run the UK's first and only Clinical Trials Support Service for people with blood cancer – helping patients get access to treatments they may have never known were available. But what is a clinical trial, and who are they available to? Read on to find out more...
Clinical trials: How we're going to make sure everyone's included
Clinical trials are a crucial part of getting new treatments to people with blood cancer. But many clinical trials struggle to recruit enough patients to take part in their research, with people from minority ethnic groups being particularly underrepresented.
My dad – the hero every story deserves
My Dad told me countless of tales and played many different characters. But in the end, when it comes to my story, he will always be the hero.
Running, research and the NHS saved my life
Last September, David teamed up with his friends and Clinical Nurse Specialists (CNS) in the Leeds 10K run to help beat blood cancer.
Why am I being invited for a third COVID vaccine dose?
Five-year-old Mila Sneddon is taking on Scoot in September to raise funds for children with blood cancer
The scooting star captured the nations hearts – including those of the Duchess of Cambridge and Ant & Dec – during lockdown when forced to isolate from her Dad during treatment
Our research investment into AML
We asked Professor Brian Huntly, an AML expert who has been working in this area for the past 18 years, why there has been so much research into AML and what he expects the future of AML research to hold.
Fears blood cancer cases are being missed, as more than half of Brits can't name symptoms
Ahead of September's Blood Cancer Awareness Month, we're calling for urgent public awareness of UK’s third biggest cancer killer
Booster vaccines: How we helped make the research happen
Beating blood cancer isn't just about spending money on research, but bringing the right people together at the right time. In this blog, we explain how we helped make booster vaccine research happen and how we see ourselves as a convener of research as well as a funder.
Can a blood test detect cancer?
You might have recently seen news suggesting that a blood test could accurately identify cancer months before a person starts to get any symptoms. Here's what we know about the test and what it might mean for people with blood cancer.
Five reasons for people with blood cancer to be hopeful about the Covid pandemic
We know that many of you are worried about Covid, which is we why we want you to know that with more research into vaccine efficacy, and with better treatments on the horizon, there are reasons for you to be optimistic about the future.
Open letter from cancer charities to the public
40 charities and organisations have written an open letter, urging the public to help keep vulnerable people safe as restrictions ease.
37 leading clinicians call for more Government support for people with blood cancer
A group of 37 leading experts representing people with blood cancer have marked the lifting of restrictions in England today (Monday) by calling on the Government to do more to protect people with blood cancer as the covid infection rate rises.
Vaccine Collaborative announce further funding for vaccine efficacy research
The Blood Cancer Vaccine Research Collaborative has announced further funding into COVID-19 vaccine research for people with blood cancer. The two new studies will seek to understand how the vaccines trigger an immune response in people with blood cancer and the extent to which this protects them from coronavirus.
